NCT04550741

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a public health problem: high prevalence; increasing morbidity and mortality; impact on health costs. Pulmonary rehabilitation (PR) is a multidisciplinary intervention combining exercise training, therapeutic education, psychosocial and behavioral interventions. Its effects are beneficial in the short and medium terms but are limited in time, between 6 and 12 months, for patients who do not pursue regular physical activity (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies. In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life. (PA) in post-rehabilitation and who do not adopt behavioral changes for health, by loss of motivation. Maintaining the long-term benefits acquired during a short-term PR program is therefore a major issue in the management of COPD. The recent development of remote rehabilitation is a promising approach that has been studied in few studies. In a randomized, controlled and multicenter study, we propose to test the hypothesis that the use of a mobile telerehabilitation solution will allow COPD patients to mainain at long-term the benefits acquired during a short-temr programm and therfore improve their quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 16, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

March 10, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 28, 2024

Completed
Last Updated

September 30, 2025

Status Verified

December 1, 2024

Enrollment Period

2.7 years

First QC Date

June 29, 2020

Last Update Submit

September 24, 2025

Conditions

Keywords

Chronic obstructive pulmonary diseaseTelerehabilitationTelemedicineExercise trainingQuality of lifeE-healthConnected objectsCare manager

Outcome Measures

Primary Outcomes (1)

  • Quality of Life of chronic obstructive pulmonary disease patients after a 1-year téléherabilitaion versus standard care program, after an initial short-term pulmonary rehabilitation program

    Quality of life assessed by the Saint Georges Respiratory Questionnaire. Three scores are calculated for the components: Symptoms; Activities; Impacts. A Total SCORE is also calculated. The minimum significant difference is 4 points.

    12 months

Secondary Outcomes (4)

  • Pre-intentional variables

    baseline

  • Post-intentional variables

    6 months

  • Physical Activity behaviors.

    12 months

  • Predictive model of physical activity behavior

    At 12 months

Study Arms (2)

Telerehabilitation

EXPERIMENTAL

Experimental group of 100 patients using the M-Réhab BPCO telerehabilitation solution. The solution will be provided during the fourth and final week of RR's stay during which patients will be trained to use all of the solution's features. Patients will carry out the entire post-rehabilitation using the remote rehabilitation solution and will benefit from medical assessments by teleconsultation at 1, 3, 6 and 12 months as well as assessments at 3, 6 and 12 months by filling. electronic auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home.

Other: telerehabilitation

Standard chronic care

NO INTERVENTION

following usual standard chronic care. Patients will receive during the last week of stay in the center, the usual advice to continue physical activity and nutritional advice at home. The evaluations at 3, 6 and 12 months will be done by electronic filling of auto-questionnaires followed by a telephone quality control if necessary. A final evaluation at 12 months, by videoconference, will be carried out at the patient's home.

Interventions

After obtaining consent, the volunteers will be included in the study at the start of the 4th week and randomized into two arms: Experimental and Control group

Also known as: Digital solution of telerehabilitation with remote connected objects
Telerehabilitation

Eligibility Criteria

Age40 Years - 78 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients diagnosed with COPD according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) creteria.
  • Presence of an incompletely reversible obstructive ventilatory disorder defined by a report VEMS / CVF lower than the lower limit of normal post-bronchodilator.
  • Patient on RR for four weeks in respiratory rehabilitation center.
  • Aged between 40 and 78 years.

You may not qualify if:

  • Presence of contraindications for exercise training (neuromuscular disease, orthopedic cause).
  • Patients with significant and unstable cardiovascular disease.
  • Inability to understand and/or answer questionnaires.
  • Refusal to use a smartphone or digital device.
  • Unable to access an internet connection at home.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre hopsitalier universitaire de Montpellier

Montpellier, Occitanie, 34295, France

Location

Clinique du Souffle

Osséja, 66340, France

Location

Related Publications (1)

  • Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O'Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013040. doi: 10.1002/14651858.CD013040.pub2.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Telerehabilitation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and ServicesTelemedicineDelivery of Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This study will be an Open study. For the primary outcome the analysis will be blind to the investigator
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2020

First Posted

September 16, 2020

Study Start

March 10, 2022

Primary Completion

November 28, 2024

Study Completion

November 28, 2024

Last Updated

September 30, 2025

Record last verified: 2024-12

Locations